Rituxan articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/08/26 21:35
2014/08/26 21:35
5d
... documentation to justify the treatments. Both audits mentioned the extended use of the drug Rituxan, in some cases for as long as six to eight years. Extended usage can cause kidney, heart,...
2014/08/26 21:35
2014/08/26 21:35
Latest videos
2014/08/25 16:17
2014/08/25 16:17
6d
... explains: Firstly, biosimilar versions of prominent off-label GVHD biologics, such as Rituxan and Campath/Lemtrada, are in very early development and are yet to succeed in clinical...
2014/08/25 12:22
2014/08/25 12:22
6d
Assuming the drug gets approved, it would complement Roche's portfolio, currently including Rituxan, Avastin and Herceptin, which are growing at mid- to high single digits. Read More: 10...
2014/08/18 17:44
2014/08/18 17:44
13d
... reaching $10.65 billion; J&J/Merck’s Remicade at $8.94 billion, and Genentech/Biogen Idec’s Rituxan at $8.92 billion. Cellcutluredish.com reports 8 of the top 15 best selling drugs in 2013...
2014/08/18 15:31
2014/08/18 15:31
13d
... the market in the United States - including blockbuster cancer therapies such as Avastin and Rituxan, both from Roche Holding AG. They are all produced from mammalian cells, often from...
2014/08/26 21:35
2014/08/26 21:35
Latest from Twitter